Negative Inotropic Effects of High Mobility Box Group 1 Protein in Isolated Contracting Cardiac Myocytes
暂无分享,去创建一个
S. Houser | D. Mann | J. Vallejo | Chen | Huei‐Ping Tzeng | Jinping Fan | J. W. Dong | Xiongwen
[1] D. Mann,et al. Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. , 2008, Texas Heart Institute journal.
[2] F. Massin,et al. High-mobility group box 1 protein plasma concentrations during septic shock , 2007, Intensive Care Medicine.
[3] K. Mani,et al. The Apoptosis Inhibitor ARC Undergoes Ubiquitin-Proteasomal-mediated Degradation in Response to Death Stimuli , 2007, Journal of Biological Chemistry.
[4] S. Akira,et al. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.
[5] S. Müller,et al. Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation , 2005, Circulation research.
[6] I. Douglas,et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[7] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[8] P. Rogalla,et al. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.
[9] U. Andersson,et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.
[10] E. Abraham,et al. Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.
[11] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Sakamoto,et al. Effect of L-canavanine, an Inhibitor of inducible nitric oxide synthase, on myocardial dysfunction during septic shock. , 2002, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[13] S. Houser,et al. Voltage‐dependent Ca2+ release from the SR of feline ventricular myocytes is explained by Ca2+‐induced Ca2+ release , 2000, The Journal of physiology.
[14] M. Boutjdir,et al. Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels. , 2000, American journal of physiology. Heart and circulatory physiology.
[15] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[16] A. Harken,et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.
[17] Anand Kumar,et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[18] C. Szabó,et al. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. , 1998, American journal of physiology. Heart and circulatory physiology.
[19] W. Lew,et al. Depyrogenation of digestive enzymes reduces lipopolysaccharide tolerance in isolated cardiac myocytes. , 1997, Journal of molecular and cellular cardiology.
[20] W. Schmitz,et al. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. , 1996, Journal of molecular and cellular cardiology.
[21] T. McKenna,et al. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. , 1995, The American journal of physiology.
[22] M. Fink,et al. Load-insensitive assessment of myocardial performance after tumor necrosis factor-alpha in dogs. , 1992, Surgery.
[23] B. Parsons,et al. Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.
[24] F. Ognibene,et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.
[25] C. Natanson,et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. , 1989, The Journal of clinical investigation.
[26] R. E. Shepherd,et al. The effect of in vivo endotoxin on myocardial function in vitro. , 1986, Circulatory shock.
[27] H. Adams,et al. Isolated cardiac preparations: models of intrinsic myocardial dysfunction in circulatory shock. , 1985, Circulatory shock.